For 2022, the company estimates that non-stock-based G&A expenses will amount to $47 to $49 million, with the increase from 2021 being primarily attributable to increased insurance costs combined with increases in travel-related costs as the restrictions arising from COVID-19 are eliminated.

Mar 11, 2022 / receipt, needs a key / Gary Brown, CFO | earnings call 2022-03-11 | transcript 00e4c9c7-fb02-4e3f-a165-9382ab271360 | chars 10007-10299 | segment 10

When COVID first started, there was the travel restrictions that for about the first six months to maybe six to nine months, we weren't able to really travel. So we did still do a very detailed desktop review. And I have to say, we also actually hired in-country consultants for the opportunities that we were looking at to actually confirm what we actually concluded from our desktop reviews. So we made sure that it still passed our hurdles, internal technical hurdles. But I also have to say that a couple of transactions that we consummated right as COVID started, we'd already visited the year before towards the tail end of the year. So, you know, we weren't really disadvantaged. About, you know, a year and a half ago, we decided we were fairly comfortable traveling. So we did travel to a lot of the sites. Sometimes that involved us coming back and quarantining in our basements for two weeks, which, you know, it wasn't a lot of fun, but we did what we had to do. And since the quarantining for two weeks has stopped, we've resumed operations as usual.

Mar 11, 2022 / receipt, needs a key / Haytham, other | earnings call 2022-03-11 | transcript 00e4c9c7-fb02-4e3f-a165-9382ab271360 | chars 30145-31208 | segment 30